Table 1.
Strains used in this study.
| Strain | Description | Source, reference |
|---|---|---|
| USA300 JE2 | CA-MRSA USA300 JE2 strain, derived from USA300 LAC | NARSA |
| NE805 | Mutant derived from USA300 JE2 strain deposited in Nebraska Transposon Mutant Library (NTML) with disrupted recA (recombinase A) gene by bursa aurealis Tn insertion | NARSA |
| NE445 | Mutant derived from USA300 JE2 strain deposited in Nebraska Transposon Mutant Library (NTML) with disrupted umuC gene by bursa aurealis Tn insertion | NARSA59 |
| 1631 | MSSA clinical isolate | This study |
| 2030 | HA-MRSA clinical isolate | This study |
| ATCC 27956 | Streptococcus agalactiae reference strain | 60 |
| EU87 | Enterococcus faecium clinical isolate with extensively drug resistance profile (XDR) | This study |